CN205215935U - Radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster - Google Patents
Radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster Download PDFInfo
- Publication number
- CN205215935U CN205215935U CN201520868043.1U CN201520868043U CN205215935U CN 205215935 U CN205215935 U CN 205215935U CN 201520868043 U CN201520868043 U CN 201520868043U CN 205215935 U CN205215935 U CN 205215935U
- Authority
- CN
- China
- Prior art keywords
- plaster
- guard section
- applied ointment
- radioiodine
- radioprotective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model relates to a radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster belongs to medical instrument preparation technical field. The utility model relates to a radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster, including surface of a wound layer (1), protection transition layer (2), inoxidizing coating (3), protection transition layer (2) comprises gas -permeable section branch (2b) and guard section (2a), guard section (2a) intussuseption is filled with the lead sheet, inoxidizing coating (3) comprise gas -permeable section branch (3a) and guard section (3b), be provided with the lead sheet in the guard section (3b), guard section (2a) is similar fitgures with gas -permeable section branch (3a), and the two area equals, guard section (3b) is similar fitgures with gas -permeable section branch (2b), and the two area equals.
Description
Technical field
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster, and belongs to medical apparatus and instruments preparing technical field.
Background technology
Thyroid carcinoma has become the fastest malignant tumor of world today's morbidity growth rate, and recent statistics result shows, and China's annual morbidity leaps to the 4th from the 8th in female malignant.Thyroid carcinoma includes thyroid papillary carcinoma, filter blocking cancer, medullary carcinoma and undifferentiated carcinoma, also has some uncommon as lymphoma and sarcoma etc.Usually said differentiated thyroid carcinoma contains thyroid papillary carcinoma and filter blocking cancer two type.Radioiodine particle therapy is one of means of current treatment of thyroid carcinoma, and doctor by the human thyroid carcinoma of radioiodine seeds implanted patient, by the internal radiation radiation effect of radioiodine particle, kills cancerous cell in operation.The iodine particle of usual patient's Post operation, implantation plays the effect continuing to kill cancerous cell in the parathyroid tissue of patient within a period of time.But iodine particle reaches the nuclear matter of 60 days as a half-life, it certainly exists the nuclear pollution risk of surrounding.
The patient that radioiodine seeds implanted is postoperative, is equal to the radioactive source of a small-sized movement.Such patient, can to medical personnel in institute and after leaving hospital, and people at one's side, particularly child and anemia of pregnant woman cause radiological detriment.But up to the present to yet there are no in any minimizing patient body radioiodine particle to the record of the medical apparatus and instruments of the radiological detriment of people around.
Utility model content
In order to reduce in patient body radioiodine particle to the radiological detriment of people around.Radioprotective after this utility model designs a kind of thyroid carcinoma radioiodine particle therapy is applied ointment or plaster.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Comprise wound surface layer (1), protection transition zone (2), overcoat (3); Described protection transition zone (2) is made up of ventilative part (2b) and guard section (2a), is filled with lead flake in described guard section (2a); Described overcoat (3) is made up of ventilative part (3a) and guard section (3b), is provided with lead flake in described guard section (3b); Described guard section (2a) is similar fitgures with ventilative part (3a), and the two area equation; Described guard section (3b) is similar fitgures with ventilative part (2b), and the two area equation.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Described wound surface layer (1), protection transition zone (2), overcoat (3) three's shape is similar, and area equation.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Described wound surface layer (1), protection transition zone (2), overcoat (3) three are rectangle.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Described wound surface layer (1), protection transition zone (2), overcoat (3) three are rectangle.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; The area of described wound surface layer (1), protection transition zone (2), overcoat (3) is 60-100cm
2.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; The thickness arranging lead flake in the lead flake of filling in described guard section (2a) and guard section (3b) is 5-6 micron.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Protection transition zone (2) is sewed with plumbous capsule.Make and form described guard section (2a) after lead flake loaded onto by the plumbous capsule of transition zone (2).
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Two surfaces up and down of overcoat (3) are defined as A face and B face respectively, and described A face contacts with protection transition zone (2); Described B face is provided with contains plumbous capsule.Lead flake is held for containing.After lead flake loaded onto by the plumbous capsule of Sheng on B face, form guard section (3b).
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Plumbous capsule and the setting of containing plumbous capsule, greatly facilitate filling and the taking-up of lead flake, so that the recycling of lead flake and sterilization.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Wound surface layer (1) contacts with the operative site of patient, and can coated medicament (as Borneolum Syntheticum, Herba Taraxaci etc.) in the one side that contacts with the operative site of patient of wound surface layer (1).
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Lead flake can also play the effect of hemostasis by compression.
Radioprotective after a kind of thyroid carcinoma radioiodine of this utility model particle therapy is applied ointment or plaster; Not only be conducive to the rehabilitation of patient, postoperative radiocontamination can also be reduced to minimum.
Accompanying drawing explanation
Accompanying drawing 1 structural representation that radioprotective is applied ointment or plaster designed by the present embodiment;
Accompanying drawing 2 radioprotective designed by the present embodiment middle protection transition zone of applying ointment or plaster makes the dress lead flake schematic diagram after plumbous capsule;
Accompanying drawing 3 radioprotective designed by the present embodiment middle overcoat of applying ointment or plaster is made and is contained the dress lead flake schematic diagram after plumbous capsule.
In Fig. 1,1 is wound surface layer; 2 is protection transition zone, and protection transition zone 2 is made up of ventilative part 2b and guard section 2a, is filled with lead flake (4) in guard section 2a; 3 is overcoat, and overcoat 3 is made up of ventilative part 3a and guard section 3b, is provided with lead flake (4) in guard section 3b.Guard section 2a and ventilative part 3a is similar fitgures, and the two area equation; Guard section 3b and ventilative part 2b is similar fitgures, and the two area equation.
In Fig. 2,2 is protection transition zone, and protection transition zone 2 is made up of ventilative part 2b and guard section 2a, and protection transition zone 2 is sewed with plumbous capsule (5).Make and load onto lead flake (4) at the plumbous capsule (5) of transition zone 2 and form described guard section 2a afterwards.In Fig. 2, lead flake (4) mates completely with plumbous capsule (5), and lead flake is divided into two parts that shape and size are completely equal by conveniently splendid attire.
In Fig. 3,2 is protection transition zone, and protection transition zone 2 is made up of ventilative part 2b and guard section 2a, and 3 is overcoat, and two surfaces up and down of overcoat 3 are A face and B face, and A face contacts with protection transition zone 2; B face is provided with the plumbous capsule of Sheng (6) and holds lead flake (4) for containing.After the plumbous capsule (6) of Sheng on B face loads onto lead flake (4), form guard section 3b.
Detailed description of the invention:
According to Fig. 1,2, the patten's design radioprotective of 3 applies ointment or plaster (rectangle), the surface area that described radioprotective is applied ointment or plaster is 84cm
2.(12cm*7cm) thickness arranging lead flake in the lead flake of filling in guard section 2a and guard section 3b is 5 microns.The area that guard section 3b arranges lead flake is 40cm
2(10cm*4cm);
The shape of the lead flake that guard section 2a is arranged and guard section 3b arrange the shape complementarity of lead flake, and the area sum of the two is 84cm
2.
Claims (8)
1. the radioprotective after a thyroid carcinoma radioiodine particle therapy is applied ointment or plaster; It is characterized in that: comprise wound surface layer (1), protection transition zone (2), overcoat (3); Described protection transition zone (2) is made up of ventilative part (2b) and guard section (2a), is filled with lead flake in described guard section (2a); Described overcoat (3) is made up of ventilative part (3a) and guard section (3b), is provided with lead flake in described guard section (3b); Described guard section (2a) is similar fitgures with ventilative part (3a), and the two area equation; Described guard section (3b) is similar fitgures with ventilative part (2b), and the two area equation.
2. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 1 is applied ointment or plaster; It is characterized in that: described wound surface layer (1), protection transition zone (2), overcoat (3) three's shape is similar, and area equation.
3. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 2 is applied ointment or plaster; It is characterized in that: described wound surface layer (1), protection transition zone (2), overcoat (3) three are rectangle.
4. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 3 is applied ointment or plaster; It is characterized in that: described wound surface layer (1), protection transition zone (2), overcoat (3) three are rectangle.
5. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 1 is applied ointment or plaster; It is characterized in that: the area of described wound surface layer (1), protection transition zone (2), overcoat (3) is 60-100cm
2.
6. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 1 is applied ointment or plaster; It is characterized in that: the thickness arranging lead flake in the lead flake of filling in described guard section (2a) and guard section (3b) is 5-6 micron.
7. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 1 is applied ointment or plaster; It is characterized in that: protection transition zone (2) is sewed with plumbous capsule; Make and form described guard section (2a) after lead flake loaded onto by the plumbous capsule of transition zone (2).
8. the radioprotective after a kind of thyroid carcinoma radioiodine particle therapy according to claim 1 is applied ointment or plaster; It is characterized in that: two surfaces up and down of overcoat (3) are defined as A face and B face respectively, described A face contacts with protection transition zone (2); Described B face is provided with contains plumbous capsule, holds lead flake for containing; After lead flake loaded onto by the plumbous capsule of Sheng on B face, form guard section (3b).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520868043.1U CN205215935U (en) | 2015-11-02 | 2015-11-02 | Radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520868043.1U CN205215935U (en) | 2015-11-02 | 2015-11-02 | Radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205215935U true CN205215935U (en) | 2016-05-11 |
Family
ID=55891033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520868043.1U Expired - Fee Related CN205215935U (en) | 2015-11-02 | 2015-11-02 | Radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205215935U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106730307A (en) * | 2017-01-04 | 2017-05-31 | 成都维宁生物技术有限公司 | Conformal therapy is pasted and its Manufacturing approach and use |
-
2015
- 2015-11-02 CN CN201520868043.1U patent/CN205215935U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106730307A (en) * | 2017-01-04 | 2017-05-31 | 成都维宁生物技术有限公司 | Conformal therapy is pasted and its Manufacturing approach and use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104001149A (en) | Traditional Chinese medicine composition for treating radiation injuries and preparation method thereof | |
| Koneru et al. | Radiotherapeutic bandage for the treatment of squamous cell carcinoma of the skin | |
| CN205215935U (en) | Radiation protection after treatment of thyroid cancer radioactivity iodine particle is applied ointment or plaster | |
| CN101926857B (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
| CN101391047A (en) | Traditional Chinese medicine preparation for treating trichonosis | |
| CN101219253B (en) | Radioactivity seed source implantation equipment | |
| CN108310173A (en) | A kind of Chinese medicine preparation of auxiliary treatment early-stage cancer and its preparation method of oral solution | |
| CN203016982U (en) | Chest radiation-proof protective plate for nuclear medicine department | |
| CN207356175U (en) | A kind of postoperative care eyeshade | |
| CN106729150A (en) | A kind of pharmaceutical formulation of skin-whitening and speckle eliminating | |
| CN208193216U (en) | A kind of sticking type radioapplicator | |
| CN203647858U (en) | Radioactive sealing seed source application for external use | |
| CN201929005U (en) | Infant traditional Chinese medicine (TCM) healthcare socks | |
| CN103960790A (en) | Camisole | |
| CN108403886A (en) | A kind of Chinese medicine surgery anesthesia agent production method | |
| CN104688816A (en) | Speckle-removing lotion | |
| CN204483142U (en) | A kind of split-type radiotherapy protective garment | |
| CN207085069U (en) | Can voluntarily fixed position radioactive particle | |
| CN107224163A (en) | A kind of anti-antihypertensive pillow | |
| CN102526385A (en) | Medicament for treating climacteric syndrome | |
| CN103285254B (en) | Traditional Chinese medicine for treating otitis and preparation method thereof | |
| CN107252225A (en) | One kind prevents and treats hypertension pillow | |
| CN210384609U (en) | Iodine-125 nuclide external irradiation therapeutic device | |
| CN202711726U (en) | Radiation-proof face shield for doctor in CT (Computed Tomogrphy) room | |
| CN105055500A (en) | Traditional Chinese medicinal prescription for treating leucoderma as well as preparation method and application method of traditional Chinese medicinal prescription |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160511 Termination date: 20161102 |